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Abstract
Background: Management of the open abdomen is an increasingly common part of surgical practice. The
purpose of this review is to examine the scientific background for the use of temporary abdominal closure (TAC) in
the open abdomen as a way to modulate the local and systemic inflammatory response, with an emphasis on
decompression after abdominal compartment syndrome (ACS).
Methods: A review of the relevant English language literature was conducted. Priority was placed on articles
published within the last 5 years.
Results/Conclusion: Recent data from our group and others have begun to lay the foundation for the concept of
TAC as a method to modulate the local and/or systemic inflammatory response in patients with an open abdomen
resulting from ACS.
Keywords: Compartment syndromes, Decompression, Laparotomy, Systemic inflammatory response syndrome,
Negative pressure dressings
Introduction
Management of the open abdomen is an increasingly
common part of modern surgical practice. Common
clinical situations that mandate the use of temporary
abdominal closure (TAC) include intra-abdominal
hypertension (IAH) with new organ dysfunction
(abdominal compartment syndrome (ACS)), intra-
abdominal sepsis without adequate source control,
damage control in trauma, and mesenteric ischemia [1].
While it is difficult to estimate the prevalence or eco-
nomic impact of the open abdomen, it is associated
with significant issues contributing to morbidity and
mortality, including development of ventral hernias,
enteroatmospheric fistulas, and un-intentional protein
loss [2].
The focus of this review is to detail current thoughts
on the use of TAC in the management of the open
abdomen, with particular attention to decompression
after ACS. We review the relevant intra-abdominal
related pathophysiology involved with ACS (with
emphasis on the gut), the different types of TAC and
evidence to support various choices. Recent data from
our group and others have begun to lay the foundation
for the concept of TAC as a method to modulate the
local and/or systemic inflammatory response after ACS.
Abdominal compartment syndrome
As defined by the International Conference of Experts
on Intra-abdominal Hypertension and Abdominal Com-
partment Syndrome (World Society of the Abdominal
Compartment Syndrome, http://www.wsacs.org), ACS is
defined as IAH (increased intra-abdominal pressure
(IAP) (> 20 mmHg)) leading to new organ dysfunction/
failure [3,4]. In general, there is improvement in organ
function after decompressive laparotomy. ACS can be
subdivided into primary, secondary and recurrent types,
depending on whether the inciting factors are abdomi-
nopelvic (primary) or in a setting free of intra-
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development of primary ACS include continued hemor-
rhage and hemorrhagic shock from trauma, decreased
space secondary to abdominal packing and bleeding, tis-
sue edema, and translocation of fluid (third spacing) [3].
Secondary ACS is more common in settings of systemic
injury (i.e., burns and or sepsis) in the setting of massive
fluid resuscitation [4]. The cornerstone of management
of ACS involves early decompressive laparotomy [5], but
mortality from ACS remains high, especially when the
diagnosis is delayed [6].
Intra-abdominal pathophysiology involved with
abdominal compartment syndrome/open abdomen:
major etiological factors
Pathophysiology relevant to a discussion of TAC after
ACS can be divided into several general processes
including global and regional ischemia/reperfusion (IR),
intestinal edema, translocation of fluid into the lumen
and peritoneal cavity (third spacing), systemic neutrophil
priming, and reperfusion related injury after abdominal
decompression.
Intestinal ischemia/reperfusion
Hemorrhagic shock followed by resuscitation leads to
intestinal injury by IR related mechanisms. The gut is
especially susceptible to shock related reductions in
blood flow secondary to both reductions in circulating
blood flow as well as shock related redistribution in
blood flow. Laboratory based studies have determined
that the kidney, stomach, and intestines experience the
greatest decrease in blood flow after hemorrhagic shock
[7]. Ischemic injury in the intestine continues to persist
after crystalloid based resuscitation [8].
The pathophysiology related to IR mediated gut injury
is similar to that affecting the lungs and kidneys; it has
been termed by some investigators as the acute intest-
inal distress syndrome [9]. IR results in mucosal damage
and increased permeability. Mucosal damage has been
attributed to numerous factors including intestinal phos-
pholipase A2 (PLA 2) mediated arachadonic acid
derived byproducts [10], mast cell infiltration and degra-
nulation [11], epithelial cell apoptosis [12], increases in
platelet activating factor (PAF) and pro-inflammatory
cytokines [13], free radical mediated injury [14], and
production of endothelins [15]. Consequences of these
interacting factors include intestinal edema.
The increase in mucosal permeability induced by gut
IR may account, in part, for distant organ injury. A
large body of literature has focused on lung injury. IR
mediated lung injury may represent a neutrophil
mediated event. Gut derived endotoxin escape into the
systemic circulation has also been implicated, potentially
through a TNF-a related mechanism [16]. Other pro-
inflammatory cytokines (e.g., IL-1a,I L - 1 b,I L - 6 ,I L - 8 ,
IL-18, cytokine-induced neutrophil chemoattractant, and
granulocyte colony stimulating factor (G-CSF)) have
also been investigated as contributors, potentially by
upregulating endothelial based participants in neutrophil
adhesion, such as E-selectin or intracellular adhesion
molecule-1 (ICAM-1) [17-20]. Membrane derived phos-
pholipids such as PAF, have also been implicated [21],
and may be involved in priming of naïve neutrophils.
Investigators have also noted PLA 2 mediated arachido-
nic acid byproducts to participate in IR mediated lung
injury [22]. Other potential mediators of distant lung
injury include toll like receptors [23], oxygen derived
free radicals [24], activation of alveolar macrophages
[24], nitric oxide [25], activation of nuclear factor - B
[26], activation of complement [27], and production of
endothelins [28]. Mesenteric lymph may represent the
major conduit for gut derived mediators of distant
organ injury, as will be described later in this review.
IR injury leads to inflammatory cell infiltration into
the intestinal muscularis and is associated with activa-
tion of transcription factors such as nuclear factor - B,
signal transduction and activator of transcription - 3
(STAT-3), and nitric oxide, and leads to ileus i [29,30].
Ileus leads to significant consequences, including delay-
ing enteral feeding and increasing the risk of septic
complications, hospital length of stay, and health care
costs [31].
Resuscitation strategies
Resuscitative strategies may play a role in the develop-
ment of secondary ACS and ACS in the open abdomen.
In particular, high volume resuscitation (in the setting
of previous IR injury) may increase risk of development
of ACS, potentially via exacerbation of organ edema.
Multiple reports have associated high volumes of crys-
talloids and/or high volume of blood products to harbor
increased risk for developing IAH and/or ACS [32-36].
Colloid based resuscitative strategies have been asso-
ciated with decreased incidence of ACS, secondary in
part to decreasing total volume of fluids administered
[34]. With the increased adoption of blood product
based resuscitative strategies, it is important to recog-
nize that administration of large amounts of blood pro-
ducts has also been associated with an increased risk of
developing ACS.
Abdominal effects of abdominal compartment syndrome/
open abdomen
Intestinal edema
Aggressive resuscitative strategies and damage control
surgical procedures alter hydrostatic and oncotic pres-
sure differentials contributing to the formation of hydro-
static intestinal edema [33-39]. Specifically, the decrease
in plasma oncotic pressures (secondary to hemodilution
from resuscitation) combined with the increase in
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(peri-hepatic) packing induced increases in mesenteric
venous pressures) leads to net efflux of fluid into the
interstitium. Contributing factors also include increased
capillary permeability from IR mediated gut injury in
the context of hemorrhagic shock/resuscitation [40-42],
and elevated central venous pressures during resuscita-
tion which prevents lymphatic mediated efflux of fluid
out of the interstitium (secondary to an elevated central
venous pressure to lymphatic flow gradient) [43,44]. The
interplay of these variables is demonstrated in Figure 1.
Edema is often viewed as an inevitable consequence of
resuscitation with little attention paid to its potential
role as an initiator and/or propagator of dysfunctional
signaling pathways. In laboratory models, intestinal
edema (in the absence of neutrophil mediated injury or
IR injury) serves to promote ileus, potentially by
activation of signal transduction cascades (nuclear factor
- B and STAT-3), decreased phosphorylation of the
regulatory myosin light chain20, and decreased intestinal
contractility [45]. Additionally, edema alters the physical
properties of the intestine, including changes in calpo-
nin, vimentin, and filamentous:globular actin, increases
in interstitial pressure, and decreases in stress and resi-
dual stiffness [45]. Certain therapies that lead to
improved intestinal transit (e.g., hypertonic saline)
reverse physical changes induced by edema [45,46]. In
addition, edema contributes to increased tissue perme-
ability [47].
In addition to edema causing ileus, there is some evi-
dence that ileus may lead to a cycle preventing edema
resolution, secondary to interference with lymphatic
mediated efflux of interstitial fluid [3,48]. Because lym-
phatic vessels within the bowel wall are valve-less [49],
Figure 1 Increased survival from traumatic injury can be attributed in part to aggressive resuscitation including early resuscitation
with crystalloid and blood products and the almost universal adoption of damage control surgical procedures (i.e., abdominal
packing). The interplay of these factors alter hydrostatic and oncotic pressure differentials contributing to the formation of hydrostatic intestinal
edema. Specifically, the decrease in plasma oncotic pressures (secondary to hemodilution from resuscitation) combined with the increase in
capillary hydrostatic pressures (secondary to abdominal (peri-hepatic) packing induced increases in mesenteric venous pressures) leads to net
efflux of fluid into the interstitium. Contributing factors also include increased capillary permeability from IR mediated gut injury in the contexto f
hemorrhagic shock/resuscitation and elevated central venous pressure during resuscitation which prevents lymphatic mediated efflux of fluid out
of the interstitium (secondary to an elevated central venous pressure to lymphatic flow gradient. In addition, edema leading to increases in IAP
can act in a feed forward manner; increases in central venous pressure (CVP) seen with increased IAPs also prevents lymphatic efflux of fluid out
of the interstitium. The decrease in cardiac output, in addition to leading to further ischemic injury, can also lead to increased administration of
fluids, worsening exacerbating hemodilution. Additionally, venous hypertension is a documented consequence of increasing IAPs, leading to
further exacerbation of intestinal edema.
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dependent on peristalsis. Therefore, decreased intestinal
contractility may prevent efflux of excess interstitial
fluid into lymphatic channels and subsequent ameliora-
tion of edema. Moore-Olufemi et al. examined the
effects of primary and secondary ACS on mesenteric
lymph flow and suggested that abdominal decompres-
sion may exert a beneficial effect on intestinal edema by
decreasing lymphatic outflow pressures, and improving
lymph mediated efflux of tissue water [50].
The abdomen as an inflammatory bioreactor
Mesenteric lymph Gut derived lymph has increasingly
been studied as a medium for systemic neutrophil prim-
ing and activation leading to distant organ injury. Early
studies indicated that mesenteric lymph sampled after
hemorrhagic shock activated neutrophils and was toxic
to endothelial cells [51]. Given the almost immediate
delivery of mesenteric derived lymph to the lungs, inter-
est grew evaluating mesenteric lymph as the responsible
agent for shock/resuscitation induced lung injury. Sub-
sequent studies confirmed these preliminary findings
and also demonstrated that mesenteric lymph repre-
sented a priming agent for naïve neutrophils, increased
E and P-selectin and ICAM-1 expression on endothelial
cells, and contributed to pro-inflammatory cytokine pro-
duction (IL-6) [52-56].
Further demonstrating this relationship, lymphatic
diversion (usually by ligation) has been shown to pre-
vent distant organ injury [53,57]. As this does not repre-
sent a translatable therapeutic strategy in most cases,
other interventions have been studied as a way to mod-
ulate post IR mesenteric lymph bioactivity, including
hypertonic saline [52,58]. In addition, the apparent role
of leukotriene B4 in lymph mediated lung injury may
offer new avenues for pharmacologic inhibition [59].
However, novel translatable ways to affect the pro-
inflammatory status of mesenteric lymph may offer pro-
mise to attenuate distant organ injury.
Peritoneal fluid Factors contributing to ACS include
translocation of gut derived interstitial fluid into the
peritoneum. Peritoneal fluid, historically, has not been
evaluated as a potential driver of systemic inflamma-
tion. Evidence from other investigators, however, indi-
cates that peritoneal fluid may be biologically active
and may represent a therapeutic target. Peritoneal
fluid from burn patients contains increased levels of
pro-inflammatory cytokines [60] and gut derived peri-
toneal fluid (accumulated during abdominal aortic
aneurysm repair) increases polymorphonuclear cell
expression of CD11b [61]. Increased concentrations of
pro-inflammatory cytokines in peritoneal fluid has
been shown to correlate with poorer outcome in burn
patients with IAH/ACS [60] and in an animal model
of peritonitis [62].
Peritoneal fluid and lymph are similar in that the
source of both is interstitial fluid. In addition to uptake
via lymphatic channels, gut derived interstitial fluid is
redistributed into the gut lumen and the peritoneal cav-
ity [63]. Adding to the potential relevance of peritoneal
fluid as an initiator and/or propagator of systemic
inflammation is the fact that peritoneal fluid is taken up
into the systemic circulation via lymphatic (primarily)
and capillary channels. This process is enhanced in the
setting of inflammation [64]. Peritoneal drainage after
cardiopulmonary bypass was associated with decreased
serum levels of pro-inflammatory cytokines [65]. Shah et
al. recently demonstrated that peritoneal fluid collected
after development of ACS primes naïve neutrophils and
monocytes via receptor dependent and independent
pathways and that decompressive laparotomy does not
significantly alter the priming capabilities of peritoneal
fluid [66]. In addition, peritoneal fluid from a model of
multiple organ dysfunction driven by gut IR and intra-
abdominal sepsis has also been shown to prime naïve
neutrophils [67]. In addition to having a potentially
bioactive role, a purely mechanical role has been sug-
gested by certain studies. Catheter drainage of ascites
may prevent the need for decompressive laparotomy in
certain cases of ACS [68].
Reperfusion syndrome after abdominal decompression
Decompressive laparotomy is widely accepted as a man-
datory intervention in patients with ACS [5]. Although
this procedure is associated with, often, immediate
improvement in some measures of organ function, little
attention is often paid to the fact that decompression
may lead to release of inflammatory mediators that
serve to propagate multiple organ dysfunction secondary
to a reperfusion like injury [69,70]. Overt reperfusion
syndrome resulting in death is rare; however, a post-
decompression reperfusion syndrome is a potential rea-
son why mortality from ACS remains high [6]. A central
component of ACS associated reperfusion syndrome
likely occurs secondary to repeated intestinal IR injury.
While most previously published animal models of
ACS poorly mimic its pathogenesis [71], they are extre-
mely useful for determining the effects of IAH, particu-
larly in the development of intestinal ischemia.
Development of ACS is associated with decreased intest-
inal perfusion, and these changes occur well before his-
tological evidence of injury [72]. Decreased local
perfusion persists even when global hemodynamic para-
meters remain within the normal range, indicating
increased IAP as an inciting factor [73]. More recent
work has begun to define the inflammatory response
initiated by abdominal decompression. Rezende-Neto et
al. demonstrated a significant increase in lung neutro-
phil myeloperoxidase, IL-6, and TNF-a after decompres-
sion from a period of ACS, suggesting decompression as
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cated in other investigations; Oda et al. demonstrated a
similar exacerbation of cytokine levels and lung injury
when evaluating a period of induced ACS after hemor-
rhagic shock/resuscitation induced injury, with levels
and injury continuing after cessation of the period of
ACS (i.e., decompression) [75]. Prior hemorrhagic
shock/resuscitation induced injury results in a lower tol-
erance for increasing IAPs with regard to end organ
injury [76]. Although ACS is not classically viewed as an
initiator of intestinal IR injury, the data presented do
serve to support this notion. Indeed, artificially induced
ACS and subsequent decompression has been used as a
model for the study of kidney IR injury and recently, to
mimic intestinal IR injury [77,78]. Additionally, the pub-
lished data on decompression leading to increased sys-
temic neutrophil activation and continued bioactivity of
peritoneal fluid, as described earlier, serve to support
the notion that decompression after ACS may serve as a
continued driver of multiple organ dysfunction. This
data also suggests that prophylactic use of the open
abdomen in certain high risk situations may affect the
course of injury by preventing a second IR injury “hit.”
The interplay of IR, resuscitation, development of ACS,
and reperfusion syndrome after decompression is
demonstrated in Figure 2.
Temporary abdominal coverage
Having elucidated major pathophysiological processes
that contribute to the development of ACS and dysfunc-
tion post-decompression, we now turn our focus to
TAC. We will briefly review the types of TAC and the
current clinical evidence supporting the use of various
forms of TAC. We focus on studies evaluating ACS and
related processes and evidence that support the notion
that TAC may modulate systemic inflammatory
processes.
Choices for temporary abdominal closure
Choice for TAC can broadly be divided into non nega-
tive pressure and negative pressure therapies.
Non negative pressure therapies The technique of
planned re-operation for intra-abdominal pathology has
been described since the 1980’s. The technique was first
widely adopted in the management of severe intra-
abdominal trauma [79]. One of the earliest methods of
temporary closure was accomplished by using towel
clips to close the skin. Although this was fast, cheap and
minimized thermal and fluid losses, there were signifi-
cant disadvantages, including the inability to visualize
the wound, possible evisceration between clips, damage
to skin, and a higher incidence of ACS due to decreased
peritoneal reserve volume [80]. Increasing peritoneal
cavity volume via the use of an artificial mesh is an
option for TAC. There are several types of mesh that
may be used, including polyglycolic acid (Vicryl™),
polypropylene (Marlex™), or polytetrafluoroethylene
(PTFE), and mesh closure techniques have been com-
bined with zipper closure techniques to allow for serial
examination of bowel [81-83]. Other options including
other absorbable meshes (e.g., polyglycolic acid
(Dexon)), biologic products, velcro-type closures (i.e.,
Wittmann Patch), and silastic sheeting have been
described in the literature [84-88]. Mesh closure techni-
ques have decreased in popularity secondary to adher-
ence of bowel to mesh and potential for injury when
taking down for re-exploration and potential for fascial
trauma and necrosis (especially with repeated explora-
tion and re-suturing) [81].
Another method of TAC is the Bogota bag, named by
Mattox while observing surgery for trauma in Colombia.
This method utilizes an intravenous fluid bag sewn to
the skin to create a translucent silo to expand the effec-
tive volume of the abdominal cavity [89]. Advantages of
this technique include speed, cost, and the ability to
serially inspect abdominal contents. Initial series of TAC
used the Bogota bag widely [90]; however, more recent
literature indicates that this technique may associated
with increased loss of fascial domain [80]. Modifications
including sewing it to the fascia and progressive tighten-
ing of the bag with decreasing intra-abdominal edema
have been described in an attempt to prevent retraction
and increase likelihood for eventual fascial closure [91].
These techniques are associated with bowel fistula for-
mation, retraction of the abdominal fascia, and intestinal
adherence to the prosthesis. Lack of hermetic closure
and efficient drainage can frequently cause profuse leak-
age of ascites, unpleasant nursing care and issues with
fluid management.
Negative pressure therapies The first reported negative
pressure assisted form of TAC was described by Schein
et al and described for the use of abdominal sepsis. The
“sandwich” technique utilized a piece of mesh sewn to
the fascia with surgical drains overlaying and coverage
with an adhesive dressing [92]. The vacuum pack
method was a derivation of this technique. Utilizing
commonly available materials (a perforated polyethylene
sheet to protect peritoneal contents, surgical towels, sili-
cone drains, and an adhesive plastic drape), an inexpen-
sive negative pressure assisted method can be quickly
fashioned. This technique was initially developed to pre-
vent fascial trauma and to facilitate nursing care
[81,93,94]. Various modifications of these techniques
have been described [83,95-97].
Another popular negative pressure TAC device is the
Vacuum Assisted Closure (VAC, Kinetic Concepts, Inc,
San Antonio, TX) therapy system. The system requires
the placement of a non-adherent perforated plastic bar-
rier over the intra-abdominal viscera, followed by
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Page 5 of 11Figure 2 The factors leading to abdominal compartment syndrome (ACS) are multifactorial, and include ischemia/reperfusion injury
from hemorrhagic shock/resuscitation, third spacing of fluid into the gut lumen, interstitium, and peritoneum secondary to
hemodilution and altered microvascular fluid flow, and polymorphonuclear (PMN) cell priming leading to distant organ injury.
Hemorrhagic shock generally has minimal effects on IAP; however, with high volume resuscitation, the interplay of increased capillary
permeability secondary to ischemia/reperfusion injury and decreased oncotic pressures (secondary to hemodilution from resuscitation) can lead
to a rapid increase in IAPs. While major effects are intra-abdominal, the interplay of these factors lead to distant organ injury, potentially through
systemic neutrophil priming and activation. Additionally, post-decompression, a reperfusion syndrome may occur and function as a second hit.
This is secondary to sudden release of flow-limiting elevated IAP, leading to recurrent gut reperfusion injury and release of pro-inflammatory
mediators. Additionally, peritoneal fluid may serve as a propogator of neutrophil priming.
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plastic sheet. An aspiration system is connected to the
sponge and a suction and negative pressure applied [98].
Many modifications of the VAC closure technique have
been described [99,100]. In addition, new commercially
available negative pressure dressings have recently been
introduced (ABThera, Kinetic Concepts, Inc, San Anto-
nio, TX; RENASYS Open Abdomen Solution, Smith and
Nephew, St. Petersburg, FL)
Evidence for temporary abdominal closure techniques
Although there are a number of individual series
describing individual institution experiences with vary-
ing forms of TAC, the focus of this review will be on
series comparing differing forms of TAC to move
towards an evidence based paradigm for choice of TACs
in differing clinical situations. There are no prospective,
randomized trials demonstrating superiority of any par-
ticular TAC technique.
Fascial closure There are few randomized trials com-
paring differing forms of TAC and eventual outcome
with regards to fascial closure. Bee et al. conducted a
randomized trial comparing VAC therapy to polyglactin
mesh and demonstrated that no significant difference in
delayed primary fascial closure rates, fistula formation
(21% versus 5%, VAC versus polyglactin mesh, respec-
tively), or intra-abdominal abscess formation. It is
important to note that the overall rate of fascial closure
(approximately 30%) is low when compared to other
series, and may have been secondary to the patient
population at the institution [101]. A recent meta-analy-
sis evaluating negative pressure therapy (VAC, vacuum
pack), Whitman patch, mesh closures (including mesh,
z i p p e r ,a n ds i l o ) ,s k i nc l o s u r e ,a n dr e t e n t i o ns u t u r e s
demonstrated that the Whitman patch, VAC therapy,
and use of retention sutures led to the highest rates of
delayed fascial closure [89].
Abdominal compartment syndrome in the open abdo-
men As indicated earlier, the fluidity of indications for
the open abdomen, especially in the setting of abdom-
inal trauma and risk factors known to harbor an
increased risk of IAH, has led to significant pre-emptive
use of TAC in an attempt to prevent development of
ACS. Despite this, there is an entity that deserves atten-
tion; namely development of ACS in the open abdomen.
Although there is scant literature on this topic, currently
published evidence suggests that vacuum assisted TAC
may harbor an increased risk of recurrent IAH and
development of recurrent ACS. Gracias et al. published
a series of development of ACS in the open abdomen
and reported 5 cases - in all cases, ACS developed
within 12 hours post-operatively and the vacuum pack
dressing was utilized as TAC [32]. Two recent labora-
tory papers also suggest that negative pressure therapy
decreases abdominal wall compliance and may harbor a
theoretical increased risk of IAH [102,103]. It is impor-
tant to note that in the Gracias series, 15 other patients
were treated with the vacuum pack dressing without
development of ACS and that there are currently no
published prospective studies evaluating the effect of
early application of vacuum assisted therapies in the set-
ting of decompression from ACS.
Mortality and outcome - clinical studies A recent
meta-analysis of series of differing TAC techniques
demonstrated that VAC therapy and the Whitman
patch were associated with the lowest mortality rates
[89]. Series comparing outcome between TAC are
almost universally retrospective. VAC therapy has been
associated with improved early control of intra-abdom-
inal pressure and normalization of lactate, faster time to
fascial closure and ventilator weaning, and decreased
intensive care unit and hospital length of stay when
compared to Bogota bag closure for decompression
from ACS. It is important to note in this series,
although the study of patients treated with VAC was
prospective, the control group was a retrospectively
evaluated cohort at the beginning timepoint of the
study. Although this study provides evidence that VAC
therapy may have a global protective effect, other
advancements in therapy and resuscitation practices
over time may have accounted for the improved out-
comes [104].
Laboratory data Although the majority of surveyed
trauma surgeons used negative pressure assisted TAC
[105], there are no prospective randomized trials
demonstrating superiority in the setting of decompres-
sion from ACS. A careful examination of current labora-
tory data is therefore imperative. We reviewed earlier
that recurrent ACS in the open abdomen was associated
in one series with use of the vacuum pack technique.
Additionally, Benninger et al. demonstrated that nega-
tive pressure therapy was associated with the lowest
abdominal volume reserve capacity (i.e., lower volume of
fluid resulted in a greater increase in IAP) in in-vitro
and in-vivo models. The authors theorized that, in the
setting of decompression from ACS, these therapies may
place one at a higher risk for recurrent IAH [102,103].
These data mandate further study into the safety of
negative pressure therapy in the immediate post-decom-
pression period.
There are few pre-clinical studies evaluating negative
pressure therapy in relevant large animal models. Kubiak
et al. recently compared VAC therapy with negative
pressure turned on to VAC therapy with negative pres-
sure off in a large animal model of multiple organ dys-
function driven by gut IR and intra-abdominal sepsis.
Notable findings included decreased mortality in the
negative pressure group along with significant ameliora-
tion of lung injury. In addition, decreased systemic
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noted [106] In a clinically severe large animal model of
non-infectious ACS, Shah et al. recently demonstrated
that immediate post-decompression application of nega-
tive pressure therapy as compared to Bogota bag closure
was associated with no increase in recurrent IAH or
worsened outcomes with regards to physiological vari-
ables, organ edema, and organ histology. Given the
small sample sizes, no conclusions could be made
regarding survival. Negative pressure therapy was asso-
ciated with reductions in central venous and mesenteric
venous pressures which over time, may be associated
with more favorable fluid flux profiles and augmented
resolution of intestinal edema [66,107,108]. These data
demonstrate that negative pressure therapy appears safe
in the immediate post-decompression period from ACS
and may be associated with improved outcomes/organ
injury parameters.
Conclusions/future study
The literature on ACS and management of the open
abdomen clearly demonstrate that prevention is the best
cure. The consequences of managing an open abdomen
are extensive; the entirely new surgical subspecialty of
complex abdominal wall reconstruction has emerged to
deal with some of these issues. Recent studies have indi-
cated that damage control laparotomy and the use of
TAC is, in some cases, overutilized [109]. Increased
recognition of the causative factors and modifications in
resuscitation strategies are serving to decrease the inci-
dence of ACS, need for decompressive laparotomy, and
consequent need for the open abdomen and TAC. We
emphasize the point that prevention of the open abdo-
men represents a far superior strategy for patient man-
agement than any form of TAC for an open abdomen
There is a lack of randomized clinical trials evaluating
the effects of a variety of TAC choices in the post
decompression period from ACS. Recent laboratory
data, however, suggest that negative pressure therapy
may be associated with a global protective effect. Poten-
tial mechanisms of benefit are currently not well under-
stood, however recent data on the pro-inflammatory
nature of peritoneal fluid in infectious and non-infec-
tious states and the role of mesenteric derived lymph in
the systemic inflammatory process offer a basis for
future study.
It is well documented that peritoneal fluid can be
reabsorbed into the systemic circulation, primarily via
lymphatic conduits [64,110]. Given this data and evi-
dence that peritoneal fluid is pro-inflammatory by repre-
senting a potential primer for naïve neutrophils, a
potential mechanism for systemic effects of peritoneal
fluid can be proposed, either as an initiator (i.e., intra-
abdominal sepsis) or propagator of systemic
inflammation. Abdominal cavity lymph has been widely
studied as a mediator of distant lung injury. Laboratory
studies have demonstrated that thoracic duct lymphatic
diversion ameliorates lung injury in the setting of gut IR
[111]. Part of the composition of thoracic duct derived
lymph is reabsorbed peritoneal fluid. Given data demon-
strating that negative pressure therapy ameliorates lung
injury, peritoneal fluid may increase the pro-inflamma-
tory characteristics of lymph given its major route of
uptake being diaphragmatic and peritoneal cavity based
lymphatic channels [106]. One potential explanation for
these observations is that augmented removal of perito-
neal fluid decreases the pro-inflammatory characteristics
of abdominal-activity derived lymph resulting in
decreased lung injury. Further study is necessary to con-
firm the hypothesis that negative pressure therapy may
be a method to decrease the pro-inflammatory nature of
abdominal cavity derived lymph.
W h i l et h ep r e p o n d e r a n c eo fd a t ad o e sn o tp r o v i d e
definitive guidelines for the management of the open
abdomen post-decompression from ACS, there is a
growing volume of literature that suggests that the
intra-abdominal cavity may be a way to modulate out-
come. Preliminary data suggests that negative pressure
therapy may be associated with a global protective effect
and this may be based via an effect on peritoneal fluid.
Further elucidation of this mechanism may allow for
improved patient outcomes by appropriate choice of
TAC.
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